Found: 50
Select item for more details and to access through your institution.
Recent Advances in the Management of Anal Cancer.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 23, p. 3010, doi. 10.3390/healthcare11233010
- By:
- Publication type:
- Article
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 12, p. 2761, doi. 10.3390/pharmaceutics15122761
- By:
- Publication type:
- Article
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13045-019-0737-2
- By:
- Publication type:
- Article
Safety of Cupping During Bevacizumab Therapy.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Impact of Treatment Sequencing on Survival for Patients with Locally Advanced Gastric Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 5, p. 2856, doi. 10.1245/s10434-020-09248-1
- By:
- Publication type:
- Article
LY3022855, an anti–colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1057, doi. 10.1007/s10637-021-01084-8
- By:
- Publication type:
- Article
The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non--Small-Cell Lung Cancer: A Mini-Review.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 5, p. 334, doi. 10.1016/j.cllc.2015.03.004
- By:
- Publication type:
- Article
Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer.
- Published in:
- Lung Cancer: Targets & Therapy, 2016, v. 7, p. 91, doi. 10.2147/LCTT.S94337
- By:
- Publication type:
- Article
A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 12, p. e2138432, doi. 10.1001/jamanetworkopen.2021.38432
- By:
- Publication type:
- Article
Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2343512, doi. 10.1001/jamanetworkopen.2023.43512
- By:
- Publication type:
- Article
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2252244, doi. 10.1001/jamanetworkopen.2022.52244
- By:
- Publication type:
- Article
Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 4, p. 1, doi. 10.1002/cam4.7076
- By:
- Publication type:
- Article
Immunotherapy in Gastroesophageal Cancers: Current Evidence and Ongoing Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association Between Spatial Heterogeneity Within Nonmetastatic Gastroesophageal Adenocarcinomas and Survival.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 4, p. e203652, doi. 10.1001/jamanetworkopen.2020.3652
- By:
- Publication type:
- Article
Bringing Personalized Medicine to Precision Medicine in Gastroesophageal Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Opinion
Keeping Checkpoint Inhibitors in Check.
- Published in:
- 2019
- By:
- Publication type:
- Opinion
Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1419338
- By:
- Publication type:
- Article
Targeting the Phosphatidylinositol-3-kinase Pathway in Gastric Cancer: Can Omics Improve Outcomes?
- Published in:
- International Neurourology Journal, 2016, v. 20, p. 131, doi. 10.5213/inj.1632740.370
- By:
- Publication type:
- Article
Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The impact of gender, race, socioeconomic status, and treatment on outcomes in esophageal cancer: A population-based analysis.
- Published in:
- Journal of Carcinogenesis, 2017, v. 16, n. 3, p. 1, doi. 10.4103/jcar.JCar_4_17
- By:
- Publication type:
- Article
The impact of gender, race, socioeconomic status, and treatment on outcomes in esophageal cancer: A population-based analysis.
- Published in:
- Journal of Carcinogenesis, 2017, v. 16, n. 1, p. 1, doi. 10.4103/jcar.JCar_4_17
- By:
- Publication type:
- Article
Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers.
- Published in:
- Diseases, 2022, v. 10, n. 2, p. 23, doi. 10.3390/diseases10020023
- By:
- Publication type:
- Article
Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers.
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. 672, doi. 10.1093/oncolo/oyae061
- By:
- Publication type:
- Article
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 905, doi. 10.1093/oncolo/oyac174
- By:
- Publication type:
- Article
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1704, doi. 10.1002/onco.13907
- By:
- Publication type:
- Article
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1538, doi. 10.1002/onco.13836
- By:
- Publication type:
- Article
Use of Molecular Assays and Circulating Tumor DNA in Early‐Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. 651, doi. 10.1002/onco.13738
- By:
- Publication type:
- Article
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET‐Amplified Esophagogastric Cancers.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1691, doi. 10.1634/theoncologist.2020-0274
- By:
- Publication type:
- Article
Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1671, doi. 10.1634/theoncologist.2020-0356
- By:
- Publication type:
- Article
The Art of Oncology: COVID‐19 Era.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 997, doi. 10.1634/theoncologist.2020-0512
- By:
- Publication type:
- Article
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e147, doi. 10.1634/theoncologist.2019-0244
- By:
- Publication type:
- Article
FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1462, doi. 10.1634/theoncologist.2019-0121
- By:
- Publication type:
- Article
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1340, doi. 10.1634/theoncologist.2019-0034
- By:
- Publication type:
- Article
Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 475, doi. 10.1634/theoncologist.2018-0602
- By:
- Publication type:
- Article
Tumor Mutational Burden Guides Therapy in a Treatment Refractory <italic>POLE‐</italic>Mutant Uterine Carcinosarcoma.
- Published in:
- Oncologist, 2018, v. 23, n. 5, p. 518, doi. 10.1634/theoncologist.2017-0342
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers.
- Published in:
- Oncologist, 2017, v. 22, n. 2, p. 152, doi. 10.1634/theoncologist.2015-0511
- By:
- Publication type:
- Article
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 11, p. 1306, doi. 10.1634/theoncologist.2016-0148
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-ResponsiveALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 762, doi. 10.1634/theoncologist.2015-0497
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1132, doi. 10.1634/theoncologist.2015-0156
- By:
- Publication type:
- Article
Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent Clinically Relevant Genomic Alterations and New Routes for Targeted Therapies.
- Published in:
- Oncologist, 2015, v. 20, n. 5, p. 499, doi. 10.1634/theoncologist.2014-0378
- By:
- Publication type:
- Article
Spontaneous Regression of Crizotinib-Associated Complex Renal Cysts During Continuous Crizotinib Treatment.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Complementary and Alternative Medicines in Prostate Cancer: From Bench to Bedside?
- Published in:
- Oncologist, 2012, v. 17, n. 6, p. 830, doi. 10.1634/theoncologist.2012-0094
- By:
- Publication type:
- Article
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51271-3
- By:
- Publication type:
- Article
Associations of baseline patient‐reported outcomes with treatment outcomes in advanced gastrointestinal cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 4, p. 619, doi. 10.1002/cncr.33315
- By:
- Publication type:
- Article
A Pilot Study of Baseline Spatial Genomic Heterogeneity in Primary Gastric Cancers Using Multi-Region Endoscopic Sampling.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00225
- By:
- Publication type:
- Article
Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01222
- By:
- Publication type:
- Article
TNS1-ALK Fusion in a Recurrent, Metastatic Uterine Mesenchymal Tumor Originally Diagnosed as Leiomyosarcoma.
- Published in:
- Acta Medica Academica, 2019, v. 48, n. 1, p. 116, doi. 10.5644/ama2006-124.248
- By:
- Publication type:
- Article
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 8, p. 1694, doi. 10.1016/j.molonc.2015.04.014
- By:
- Publication type:
- Article